TehranDarou Pharmaceutical Co.
Tehran Daru Pharmaceutical Co. is a privately held Iranian pharmaceutical manufacturer in Tehran that produces 200+ generic medicines and supplements across 14 therapeutic categories, distributing domestically through six named partners and 10+ sales centers while exporting to Iraq, Syria, and Afghanistan.
- Company typePrivate
- Founded1955
- HeadquartersTehran, Iran
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What TehranDarou Pharmaceutical Co. does
Tehran Daru Pharmaceutical Co. (شرکت داروسازی تهران دارو) is a privately held Iranian pharmaceutical manufacturer headquartered in Tehran that produces over 200 generic medicines and nutritional supplements across 14 therapeutic categories, including cardiovascular, central nervous system, antimicrobials, analgesics, antidiabetics, gastrointestinal, anti-allergy, musculoskeletal, immunosuppressants, and supplements. The company's core technology is a GMP-certified oral solid-dose production line (GMP certificate obtained May 2018) supported by a multi-laboratory quality control system (Central, Eastern, and Lashgari labs) and a production unit staffed by over 100 skilled personnel. Tehran Daru was founded in 1955 as Mysin Laboratory (renamed and privatized in the late 1990s), giving it a 70-year operating heritage in the Iranian market. Its portfolio spans commodity generics (Acetaminophen, Cetirizine, Loperamide) to specialty therapeutics (Pirfenidone, Apixaban, Aripiprazole, Atomoxetine).
Tehran Daru sells its products through six named distribution partners (Nokhbegan Distribution, Vana Distribution, Iran Hormone, Tehran Chemie, Afa Chemistry, Hakim Pharm), over 10 sales centers across Iran, and a field force of medical representatives conducting physician outreach. Dedicated portals serve physicians/specialists and patients, and the company operates an adverse drug reaction reporting channel. Pricing is regulated by Iranian national health authorities, with no public price disclosure on individual products. The company also operates a dedicated export department and ships to Iraq, Syria, and Afghanistan, though international sales represent a smaller secondary revenue stream relative to the domestic Iranian market.
The company employs 300+ personnel across production, quality control, sales, marketing, finance, IT, planning/warehousing, engineering, human resources, and project management functions. Leadership includes Dr. Masoud Abdolkarimi as CEO, Leila Soleimaninezhad as Managing Director (also leading the export department), and dedicated technical managers for pharmaceutical and supplementary medicines. The company holds ISO 45001 occupational health and safety management and pursues ongoing modernization of its manufacturing infrastructure. Revenue is not publicly disclosed, and Tehran Daru operates as a privately held corporation with no institutional investors, subsidiaries, or public shareholders identified in the source material.
TehranDarou Pharmaceutical Co. firmographics
Firmographics- Name
- TehranDarou Pharmaceutical Co.
- Legal name
- Tehran Daru Pharmaceutical Co. (شرکت داروسازی تهران دارو)
- Website
- https://tehrandarou.com
- Company type
- Private
- Founded year
- 1955
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Tehran Daru Pharmaceutical Co. is a privately held Iranian pharmaceutical manufacturer in Tehran that produces 200+ generic medicines and supplements across 14 therapeutic categories, distributing domestically through six named partners and 10+ sales centers while exporting to Iraq, Syria, and Afghanistan.
- Ownership category
- akta.pro rank
TehranDarou Pharmaceutical Co. industry classification
Industry- Product category
- Generic Pharmaceuticals Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Specialty Care Pharmaceuticals (HLAIAAAB), Generic Hospital & Institutional Products (HLAIABAL), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)
Keywords
Where TehranDarou Pharmaceutical Co. is headquartered
LocationHeadquarters
- HQ city
- Tehran
- HQ country
- Iran
- HQ region
- Middle East
Offices1 record
Markets served
TehranDarou Pharmaceutical Co. business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Product Sales: Tehran Daru manufactures and sells prescription and OTC pharmaceutical products across 14 drug categories including cardiovascular, CNS, analgesics, antimicrobials, antidiabetics, and supplements. Products are distributed domestically through a network of distribution partners and sold via retail pharmacies. The company also exports to Iraq, Syria, and Afghanistan.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
TehranDarou Pharmaceutical Co. product offering
Product offeringCore offering
Tehran Daru manufactures and markets over 200 generic pharmaceutical products and nutritional supplements across 14 therapeutic categories, including cardiovascular, central nervous system, antimicrobials, analgesics, antidiabetics, gastrointestinal, anti-allergy, musculoskeletal, immunosuppressants, and supplements. Production is centered on a GMP-certified oral solid-dose line, with products distributed domestically through a partner network and exported to Iraq, Syria, and Afghanistan.
Product overview
TehranDarou Pharmaceutical Co. is an Iranian pharmaceutical manufacturer producing a diverse portfolio of generic medications and nutritional supplements. The product portfolio includes: (1) Antimicrobial medications such as Fluconazole and Aciclovir; (2) Cardiovascular medications including Tranexamic acid, Apixatan (Apixaban), asapted (Aspirin), Amloted, Ezited, and Eplerenone; (3) Central Nervous System medications including ALPRAZOLAM, Aripify (Aripiprazole), Atomoxetine, and ESCITALOTED; (4) Analgesics including Tedaphen Lysine (Ibuprofen Lysine), ACETAMIN, and Ibuprofen/Methocarbamol combinations; (5) Anti-allergy medication Aller Off (Cetirizine); (6) Gastrointestinal medication Lomidex (Loperamide); (7) Immunosuppressant Pirfenidone; (8) Nutritional supplements including Calcium+D3, Caffeine, Vitamin D3/Omega 3, and L-Arginine. The company operates under GMP certification and exports to regional markets including Iraq, Syria, and Afghanistan.
Differentiator
Problem solved
Functional benefit
Products and services
- Fluconazole 100
- Tranexamic acid 250mg
- Tedaphen Lysine
- Calcium+D3
- Lomidex (Loperamide)
- Pirfenidone 200mg
- Caffeine 200mg
- Ibuprofen 200mg / Methocarbamol 500mg
- Vitamin D3 / Omega 3
- ALPRAZOLAM
- Aller Off (Cetirizine)
- Aciclovir
- Asapted (Acetyl Salicylic Acid)
- Aripify (Aripiprazole)
- Atomoxetine
- Apixatan (Apixaban)
- ESCITALOTED (Escitalopram)
Quantifiable outcome
- Over 200 pharmaceutical products manufactured and marketed
- +2 more outcomes
Companies that use TehranDarou Pharmaceutical Co.
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles3 records
TehranDarou Pharmaceutical Co. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
TehranDarou Pharmaceutical Co. partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- داروگستر نخبگان (Nokhbegan Distribution)coreNamed distribution partner for Tehran Daru pharmaceutical products, distributing medications to retail pharmacies across Iran.
- وانا داروگستر (Vana Distribution)coreNamed distribution partner for Tehran Daru pharmaceutical products.
- شرکت ایران هورمون (Iran Hormone)coreNamed distribution partner for Tehran Daru pharmaceutical products.
- شرکت داروسازی تهران شیمی (Tehran Chemie)coreNamed distribution partner for Tehran Daru pharmaceutical products.
- شرکت داروسازی آفاشیمی (Afa Chemistry)coreNamed distribution partner for Tehran Daru pharmaceutical products.
- شرکت داروسازی حکیم (Hakim Pharm)coreNamed distribution partner for Tehran Daru pharmaceutical products.
Scale indicators6 records
Recent moves6 records
Expansion highlights4 records
TehranDarou Pharmaceutical Co. competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
TehranDarou Pharmaceutical Co. social profiles
Digital presenceTehranDarou Pharmaceutical Co. compliance and trust
Trust signalCompliance3 records
TehranDarou Pharmaceutical Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
TehranDarou Pharmaceutical Co. leadership team
Management profileNumber of profiles
Profiles13 records
TehranDarou Pharmaceutical Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TehranDarou Pharmaceutical Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TehranDarou Pharmaceutical Co.
What does TehranDarou Pharmaceutical Co. do?
Tehran Daru manufactures and markets over 200 generic pharmaceutical products and nutritional supplements across 14 therapeutic categories, including cardiovascular, central nervous system, antimicrobials, analgesics, antidiabetics, gastrointestinal, anti-allergy, musculoskeletal, immunosuppressants, and supplements. Production is centered on a GMP-certified oral solid-dose line, with products distributed domestically through a partner network and exported to Iraq, Syria, and Afghanistan.
Is TehranDarou Pharmaceutical Co. a public or private company?
TehranDarou Pharmaceutical Co. is a private company. It is classified as unknown and is currently operating.
When was TehranDarou Pharmaceutical Co. founded?
TehranDarou Pharmaceutical Co. was founded in 1955. It employs 11 to 50 people.
Where is TehranDarou Pharmaceutical Co. based?
TehranDarou Pharmaceutical Co. is headquartered in Tehran, Iran, in the Middle East region.
How does TehranDarou Pharmaceutical Co. make money?
One revenue line is on record: pharmaceutical Product Sales.
Does TehranDarou Pharmaceutical Co. have an API?
No public API is recorded for TehranDarou Pharmaceutical Co..
What industry is TehranDarou Pharmaceutical Co. in?
TehranDarou Pharmaceutical Co.'s product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.